Edition:
United States

Intersect Ent Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

30.60USD
14 Dec 2018
Change (% chg)

$-1.60 (-4.97%)
Prev Close
$32.20
Open
$31.95
Day's High
$31.97
Day's Low
$30.56
Volume
85,596
Avg. Vol
92,351
52-wk High
$42.90
52-wk Low
$25.15

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: --
Market Cap(Mil.): $894.66
Shares Outstanding(Mil.): 29.19
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 32.18 34.39
EPS (TTM): -0.70 -- --
ROI: -16.93 13.76 14.96
ROE: -17.07 16.50 16.52

Earnings vs. Estimates